The Sigma‐1 Gene as a Prognostic Marker in Chemotherapy‐Treated Breast Cancer‐Antagonists' Synergism With Paclitaxel In Vitro

Treatment benefits of paclitaxel (Px)‐based chemotherapy are often offset by dose‐limiting side effects. The sigma‐1 receptor (Sig1R) is implicated in chemotherapy (ChT)‐induced neuropathy but its role in the metastatic potential of breast cancer (BCa) has not been properly explored.

• Publication year

  2025

• Venue

  Cancer Medicine

• Publication date

  2025-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cam4.71376PMID 41223123PMCID 12611308
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial

  2025cited by this paper
• Development of Carbon‐11 Labeled Pyrimidine Derivatives as Novel Positron Emission Tomography (PET) Agents Enabling Brain Sigma‐1 Receptor Imaging

  2025cited by this paper
• Sigma1 Regulates Lipid Droplet–Mediated Redox Homeostasis Required for Prostate Cancer Proliferation

  2023cited by this paper
• Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders

  2023cited by this paper
• SIGMAR1 Confers Innate Resilience against Neurodegeneration

  2023cited by this paper
• TRPA1 modulation by Sigma-1 receptor prevents oxaliplatin-induced painful peripheral neuropathy

  2022cited by this paper
• An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer

  2022influential reference
• Study of the Relationship between Sigma Receptor Expression Levels and Some Common Sigma Ligand Activity in Cancer Using Human Cancer Cell Lines of the NCI-60 Cell Line Panel

  2021cited by this paper
• Weekly Paclitaxel-Induced Neurotoxicity in Breast Cancer: Outcomes and Dose Response.

  2021cited by this paper
• The aftermath of the interplay between the endoplasmic reticulum stress response and redox signaling

  2021cited by this paper
• Approaches to PET Imaging of Glioblastoma

  2020cited by this paper
• The integrated stress response: From mechanism to disease

  2020cited by this paper
• Ca2+ Release by IP3 Receptors Is Required to Orient the Mitotic Spindle

  2020cited by this paper
• Identification of specific modules and significant genes associated with colon cancer by weighted gene co‑expression network analysis.

  2019cited by this paper
• The Sigma-1 Receptor in Cellular Stress Signaling

  2019cited by this paper
• Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes

  2019cited by this paper
• Personalized Management of Chemotherapy‐Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)

  2019cited by this paper
• The Sigma-1 Receptor: When Adaptive Regulation of Cell Electrical Activity Contributes to Stimulant Addiction and Cancer

  2019cited by this paper
• Combined treatment of ABT199 and irinotecan suppresses KRAS-mutant lung cancer cells.

  2019influential reference
• Combination of the natural product capsaicin and docetaxel synergistically kills human prostate cancer cells through the metabolic regulator AMP-activated kinase

  2019cited by this paper
• Methylglyoxal in combination with 5-Fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle inhibition.

  2019cited by this paper
• Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.

  2017cited by this paper
• Small-Molecule Sigma1 Modulator Induces Autophagic Degradation of PD-L1

  2017cited by this paper
• Store-Operated Ca2+ Entry Controls Induction of Lipolysis and the Transcriptional Reprogramming to Lipid Metabolism.

  2017cited by this paper
• Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial

  2017cited by this paper
• The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca2+ homeostasis

  2017cited by this paper
• ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases

  2016cited by this paper
• Protein misfolding in the endoplasmic reticulum as a conduit to human disease

  2016cited by this paper
• The selective sigma-1 receptor antagonist E-52862 attenuates neuropathic pain of different aetiology in rats

  2016cited by this paper
• The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems.

  2016cited by this paper
• SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness.

  2016cited by this paper
• Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid

  2015cited by this paper
• The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands.

  2015cited by this paper
• Sigma-1 Receptor Antagonist BD1047 Reduces Mechanical Allodynia in a Rat Model of Bone Cancer Pain through the Inhibition of Spinal NR1 Phosphorylation and Microglia Activation

  2015cited by this paper
• Taxol-induced unfolded protein response activation in breast cancer cells exposed to hypoxia: ATF4 activation regulates autophagy and inhibits apoptosis.

  2015cited by this paper
• Fluvoxamine alleviates paclitaxel-induced neurotoxicity

  2015cited by this paper
• Sigma-1 receptor antagonist, BD1047 reduces nociceptive responses and phosphorylation of p38 MAPK in mice orofacial formalin model.

  2014cited by this paper
• Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice

  2014influential reference
• Ion channels and apoptosis in cancer

  2014cited by this paper
• Fluvoxamine alleviates ER stress via induction of Sigma-1 receptor

  2014cited by this paper
• How Taxol/paclitaxel kills cancer cells

  2014cited by this paper
• The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by Ligands

  2014cited by this paper
• Sigma-1 Receptor Chaperone at the ER-Mitochondrion Interface Mediates the Mitochondrion-ER-Nucleus Signaling for Cellular Survival

  2013cited by this paper
• Sequential Cytoprotective Responses to Sigma1 Ligand–Induced Endoplasmic Reticulum Stress

  2013cited by this paper
• Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer.

  2013cited by this paper
• Cell volume regulation in epithelial physiology and cancer

  2013cited by this paper
• Inhibition of tumor cell growth by Sigma1 ligand mediated translational repression.

  2012cited by this paper
• Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice.

  2012cited by this paper
• A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.

  2011cited by this paper
• Drug combination studies and their synergy quantification using the Chou-Talalay method.

  2010influential reference
• Effect of training-sample size and classification difficulty on the accuracy of genomic predictors

  2010cited by this paper
• The sigma-1 receptor chaperone as an inter-organelle signaling modulator.

  2010cited by this paper
• The Antinociceptive Effect of Sigma-1 Receptor Antagonist, BD1047, in a Capsaicin Induced Headache Model in Rats.

  2009cited by this paper
• Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

  2008cited by this paper
• Intrathecal Injection of the &sfgr;1 Receptor Antagonist BD1047 Blocks Both Mechanical Allodynia and Increases in Spinal NR1 Expression during the Induction Phase of Rodent Neuropathic Pain

  2008cited by this paper
• The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy

  2008cited by this paper
• Cancer Cell Cycle Modulated by a Functional Coupling between Sigma-1 Receptors and Cl– Channels*

  2007cited by this paper
• Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival.

  2007cited by this paper
• Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies

  2006influential reference
• Expression of sigma 1 receptor in human breast cancer

  2004cited by this paper
• Inhibition of Tumor Cell Proliferation by (cid:1) Ligands Is Associated with K (cid:1) Channel Inhibition and p27 kip1 Accumulation

  2004cited by this paper
• Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.

  2004cited by this paper
• Inhibition of Tumor Cell Proliferation by σ Ligands Is Associated with K+ Channel Inhibition and p27kip1 Accumulation

  2004cited by this paper

• No citing papers are available for this paper.